Apixaban

Population Pharmacokinetics of Apixaban in Asian Patients With Atrial Fibrillation

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

Anticoagulation in Patients With Venous Thromboembolism and Cancer

Apixaban Versus Enoxaparin for Postpartum Venous Thromboembolism Prophylaxis

Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease

Apixaban Versus Warfarin for Left Ventricular Thrombus

Apixaban vs Rivaroxaban vs No Anticoagulant to Prevent EHIT After Great Saphenous Vein Laser Ablation

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants

Bariatric Surgery and Pharmacokinetics of Apixaban

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

Thromboprophylaxis in Lower Limb Immobilisation

High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France

Comparison of Bleeding Risk Between Rivaroxaban and Apixaban for the Treatment of Acute Venous Thromboembolism

Comparison of Apixaban Versus Enoxaparin

Comparing the Safety and Efficacy of Apixaban and Rivaroxaban

AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation

Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation

THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation